Literature DB >> 25065669

A survey of detergents for the purification of stable, active human cystic fibrosis transmembrane conductance regulator (CFTR).

Ellen Hildebrandt1, Qinghai Zhang2, Natasha Cant3, Haitao Ding4, Qun Dai4, Lingling Peng2, Yu Fu2, Lawrence J DeLucas5, Robert Ford3, John C Kappes6, Ina L Urbatsch7.   

Abstract

Structural knowledge of the cystic fibrosis transmembrane conductance regulator (CFTR) requires developing methods to purify and stabilize this aggregation-prone membrane protein above 1mg/ml. Starting with green fluorescent protein- and epitope-tagged human CFTR produced in mammalian cells known to properly fold and process CFTR, we devised a rapid tandem affinity purification scheme to minimize CFTR exposure to detergent in order to preserve its ATPase function. We compared a panel of detergents, including widely used detergents (maltosides, neopentyl glycols (MNG), C12E8, lysolipids, Chaps) and innovative detergents (branched alkylmaltosides, facial amphiphiles) for CFTR purification, function, monodispersity and stability. ATPase activity after reconstitution into proteoliposomes was 2-3 times higher when CFTR was purified using facial amphiphiles. ATPase activity was also demonstrated in purified CFTR samples without detergent removal using a novel lipid supplementation assay. By electron microscopy, negatively stained CFTR samples were monodisperse at low concentration, and size exclusion chromatography showed a predominance of monomer even after CFTR concentration above 1mg/ml. Rates of CFTR aggregation quantified in an electrophoretic mobility shift assay showed that detergents which best preserved reconstituted ATPase activity also supported the greatest stability, with CFTR monomer half-lives of 6-9days in MNG or Chaps, and 12-17days in facial amphiphile. Cryoelectron microscopy of concentrated CFTR in MNG or facial amphiphile confirmed mostly monomeric protein, producing low resolution reconstructions in conformity with similar proteins. These protocols can be used to generate samples of pure, functional, stable CFTR at concentrations amenable to biophysical characterization.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ABC transporter; ATP-binding cassette; Cystic fibrosis; Facial amphiphiles; Maltoside neopentyl glycol detergents

Year:  2014        PMID: 25065669      PMCID: PMC4170525          DOI: 10.1016/j.bbamem.2014.07.016

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  49 in total

1.  Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion.

Authors:  Tonghui Ma; Jay R Thiagarajah; Hong Yang; Nitin D Sonawane; Chiara Folli; Luis J V Galietta; A S Verkman
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

2.  Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein.

Authors:  I L Urbatsch; M K al-Shawi; A E Senior
Journal:  Biochemistry       Date:  1994-06-14       Impact factor: 3.162

3.  A fluorimetric method for the estimation of the critical micelle concentration of surfactants.

Authors:  E De Vendittis; G Palumbo; G Parlato; V Bocchini
Journal:  Anal Biochem       Date:  1981-08       Impact factor: 3.365

4.  The First Nucleotide Binding Domain of Cystic Fibrosis Transmembrane Conductance Regulator Is a Site of Stable Nucleotide Interaction, whereas the Second Is a Site of Rapid Turnover.

Authors:  Luba Aleksandrov; Andrei A Aleksandrov; Xiu-Bao Chang; John R Riordan
Journal:  J Biol Chem       Date:  2002-02-22       Impact factor: 5.157

5.  Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  Mark F Rosenberg; Alhaji Bukar Kamis; Luba A Aleksandrov; Robert C Ford; John R Riordan
Journal:  J Biol Chem       Date:  2004-07-09       Impact factor: 5.157

6.  Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  C E Bear; C H Li; N Kartner; R J Bridges; T J Jensen; M Ramjeesingh; J R Riordan
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

7.  Characterization of the adenosinetriphosphatase and transport activities of purified cystic fibrosis transmembrane conductance regulator.

Authors:  Christian J Ketchum; Garnepudi V Rajendrakumar; Peter C Maloney
Journal:  Biochemistry       Date:  2004-02-03       Impact factor: 3.162

8.  Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding.

Authors:  J Logan; D Hiestand; P Daram; Z Huang; D D Muccio; J Hartman; B Haley; W J Cook; E J Sorscher
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

Review 9.  CFTR structure and cystic fibrosis.

Authors:  Natasha Cant; Naomi Pollock; Robert C Ford
Journal:  Int J Biochem Cell Biol       Date:  2014-02-15       Impact factor: 5.085

10.  Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins.

Authors:  C L Ward; R R Kopito
Journal:  J Biol Chem       Date:  1994-10-14       Impact factor: 5.157

View more
  5 in total

1.  Specific stabilization of CFTR by phosphatidylserine.

Authors:  Ellen Hildebrandt; Netaly Khazanov; John C Kappes; Qun Dai; Hanoch Senderowitz; Ina L Urbatsch
Journal:  Biochim Biophys Acta Biomembr       Date:  2016-11-30       Impact factor: 3.747

2.  A stable human-cell system overexpressing cystic fibrosis transmembrane conductance regulator recombinant protein at the cell surface.

Authors:  Ellen Hildebrandt; Alok Mulky; Haitao Ding; Qun Dai; Andrei A Aleksandrov; Bekim Bajrami; Pamela Ann Diego; Xing Wu; Marjorie Ray; Anjaparavanda P Naren; John R Riordan; Xudong Yao; Lawrence J DeLucas; Ina L Urbatsch; John C Kappes
Journal:  Mol Biotechnol       Date:  2015-05       Impact factor: 2.695

3.  Substitution of Yor1p NBD1 residues improves the thermal stability of Human Cystic Fibrosis Transmembrane Conductance Regulator.

Authors:  B M Xavier; E Hildebrandt; F Jiang; H Ding; J C Kappes; I L Urbatsch
Journal:  Protein Eng Des Sel       Date:  2017-10-01       Impact factor: 1.650

4.  Sites associated with Kalydeco binding on human Cystic Fibrosis Transmembrane Conductance Regulator revealed by Hydrogen/Deuterium Exchange.

Authors:  Laura J Byrnes; Yingrong Xu; Xiayang Qiu; Justin D Hall; Graham M West
Journal:  Sci Rep       Date:  2018-03-16       Impact factor: 4.379

5.  Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR).

Authors:  Stephanie Chin; Mohabir Ramjeesingh; Maurita Hung; June Ereño-Oreba; Hong Cui; Onofrio Laselva; Jean-Philippe Julien; Christine E Bear
Journal:  Cells       Date:  2019-07-31       Impact factor: 6.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.